Search Grant Opportunities

Cell and Gene Therapies for HIV Cure: Developing a Pipeline (P01 Clinical Trial Not Allowed)

ID: RFA-AI-24-013 • Type: Posted
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Sign in to upload a capability statement or catalogue for your company

Some suggestions:
Please summarize the work to be completed under this opportunity
Who is eligible to apply for this grant?
I'd like to anonymously submit a question to the procurement officer(s)
Loading

Description

Posted: April 8, 2024, 12:00 a.m. EDT
The purpose of this Notice of Funding Opportunity (NOFO) is to support multi-project research programs for the development, characterization, and advancement of gene- and cell-based approaches to achieve long-term remission or elimination of HIV. Approaches will eventually be evaluated in the clinic, rendered scalable and deliverable. Applications are expected to include basic science discovery as well as preclinical research activities such as test-of-concept studies in animal models. Applicants are required to include one or more private sector partner to participate in their program.
Posted: Feb. 22, 2024, 12:00 a.m. EST
Posted: Feb. 22, 2024, 12:00 a.m. EST
Background
The purpose of this Notice of Funding Opportunity (NOFO) is to support multi-project research programs for the development, characterization, and advancement of gene- and cell-based approaches to achieve long-term remission or elimination of HIV. The Department of Health and Human Services, specifically the National Institutes of Health (NIH), including the National Institute of Allergy and Infectious Diseases (NIAID), the National Heart, Lung, and Blood Institute (NHLBI), and the National Institute of Mental Health (NIMH), is issuing this grant opportunity. The goal is to develop innovative gene- and/or cell-based HIV cure approaches, leveraging recent insights into virus-host interactions, genotype and phenotype of HIV latent cells, and reservoir cell survival and proliferation.

Grant Details
The grant aims to support integrated multi-project research programs applying emerging and improved technologies to the development of innovative gene- and/or cell-based HIV cure approaches. Private sector partnerships are required to facilitate development of strategies appropriate for clinical studies and ultimately commercialization, if proven to be safe and effective. The program structure includes an Administrative Core providing management, coordination, and supervision; optional Scientific Cores providing resources essential for the activities of two or more Research Projects; and required Research Projects integrated in the Program overall. The application must provide a Milestone Plan with timelines for significant research outcomes, criteria for evaluating progress, plans for an INTERACT meeting with the FDA early in product development, a Scientific Advisory Board after award to review progress, annual meetings for all Key Personnel, SAB members and NIAID staff to review goals and milestones achieved during the year.

Eligibility Requirements
Eligible applicants include higher education institutions, nonprofits with 501(c)(3) IRS status, for-profit organizations including small businesses, local governments, state governments, federal governments, U.S. Territory or Possession entities, independent school districts, public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), faith-based or community-based organizations. Foreign organizations are not eligible to apply directly but non-domestic components of U.S. Organizations are eligible. Eligible individuals with the skills necessary to carry out the proposed research as Program Director(s)/Principal Investigator(s) are encouraged to apply.

Period of Performance
The period of performance should reflect the scope of the proposed project with a maximum requested project period of 5 years.

Grant Value
The total funding commitment from NIH components in FY 2025 includes $6.5 million from NIAID, $6.5 million from NHLBI, $0.25 million from NIMH for a total of 3-4 awards. Application budgets are not expected to exceed $2.2M in direct costs per year.

Overview

On 4/8/24 the National Institutes of Health posted grant opportunity RFA-AI-24-013 for Cell and Gene Therapies for HIV Cure: Developing a Pipeline (P01 Clinical Trial Not Allowed). The grant will be issued under grant program 93.233 National Center on Sleep Disorders Research.

Timing

Posted Date
April 8, 2024, 12:00 a.m. EDT
Closing Date
July 30, 2024, 12:00 a.m. EDT Past Due
Last Updated
April 8, 2024, 11:33 a.m. EDT
Version
1
Archive Date
Sept. 4, 2024

Eligibility

Eligible Applicants
Special district governments
Public housing authorities/Indian housing authorities
City or township governments
For profit organizations other than small businesses
Small businesses
Private institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Public and State controlled institutions of higher education
Independent school districts
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
State governments
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Native American tribal governments (Federally recognized)
County governments
Additional Info
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organization) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Contacts

Contact
National Institutes of Health
Contact Email
Email Description
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Contact Phone
(301) 402-2541
Additional Information
https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-24-013.html

Documents

Posted documents for RFA-AI-24-013

Grant Awards

Grants awarded through RFA-AI-24-013

Incumbent or Similar Grants

Grants similar to RFA-AI-24-013

Similar Active Opportunities

Open grant opportunities similar to RFA-AI-24-013